It is documented that TLR4 activation promotes carcinogenesis and resistance to chemical treatments in breast cancer [49, 50], whereas blocking TLR4 activation can slow breast cancer growth and prolong survival [2]. The gene discussed is TLR4; the disease is breast cancer.